|
Symbol |
Object Name |
Qualifiers |
Evidence |
Notes |
Source |
PubMed Reference(s) |
RGD Reference(s) |
Position |
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; icaritin inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]; icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; PPARG protein affects the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]] 2-chloro-5-nitrobenzanilide inhibits the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] |
CTD |
PMID:34153405 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
increases expression |
EXP |
icaritin results in increased expression of ALPL mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
increases expression |
EXP |
icaritin results in increased expression of BGLAP mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Chat |
choline O-acetyltransferase |
increases expression |
ISO |
icaritin results in increased expression of CHAT protein |
CTD |
PMID:19135036 |
|
NCBI chr16:7,663,665...7,723,416
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
ISO |
icaritin inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA] icaritin inhibits the reaction [Bleomycin results in increased expression of COL1A1 mRNA]; icaritin inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; PPARG protein affects the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]] |
CTD |
PMID:34153405 |
|
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
increases expression |
EXP |
icaritin results in increased expression of COL1A2 mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:32,563,381...32,598,867
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions increases expression |
ISO |
icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of and affects the localization of CTNNB1 protein]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of CTNNB1 mRNA] icaritin results in increased expression of CTNNB1 mRNA; icaritin results in increased expression of CTNNB1 protein |
CTD |
PMID:30731080 |
|
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
ISO |
icaritin results in decreased activity of CYP1A2 protein |
CTD |
PMID:29753067 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases activity |
ISO |
icaritin results in decreased activity of CYP2C19 protein |
CTD |
PMID:29753067 |
|
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing affects activity |
ISO |
CYP3A4 protein results in increased metabolism of icaritin icaritin affects the activity of CYP3A4 protein |
CTD |
PMID:29753067 PMID:30938510 |
|
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases metabolic processing |
ISO |
CYP3A5 protein results in increased metabolism of icaritin |
CTD |
PMID:30938510 |
|
NCBI chr12:21,919,955...21,960,160
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Dkk1 |
dickkopf WNT signaling pathway inhibitor 1 |
decreases expression multiple interactions |
ISO |
icaritin results in decreased expression of DKK1 mRNA; icaritin results in decreased expression of DKK1 protein icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in increased expression of DKK1 protein] |
CTD |
PMID:30731080 |
|
NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:228,381,521...228,385,202
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions increases activity |
ISO |
[Fulvestrant binds to and results in decreased activity of ESR1 protein] inhibits the reaction [icaritin results in increased activity of ESR1 protein] |
CTD |
PMID:22613215 |
|
NCBI chr 1:43,511,685...43,904,454
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases activity multiple interactions |
ISO |
icaritin results in increased activity of ESR2 protein [4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol results in decreased activity of ESR2 protein] inhibits the reaction [icaritin results in increased activity of ESR2 protein] |
CTD |
PMID:22613215 |
|
NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fgf5 |
fibroblast growth factor 5 |
increases expression |
ISO |
icaritin results in increased expression of FGF5 mRNA |
CTD |
PMID:19135036 |
|
NCBI chr14:11,627,906...11,650,243
Ensembl chr14:11,325,334...11,345,997
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions increases phosphorylation |
ISO |
icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased phosphorylation of GSK3B protein] icaritin results in increased phosphorylation of GSK3B protein |
CTD |
PMID:30731080 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Ldha |
lactate dehydrogenase A |
decreases expression multiple interactions |
ISO |
icaritin results in decreased expression of LDHA mRNA; icaritin results in decreased expression of LDHA protein Acetylcysteine inhibits the reaction [icaritin results in decreased expression of LDHA protein]; pifithrin inhibits the reaction [icaritin results in decreased expression of LDHA mRNA]; pifithrin inhibits the reaction [icaritin results in decreased expression of LDHA protein] |
CTD |
PMID:38431053 |
|
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions increases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [icaritin results in increased phosphorylation of MAPK14 protein]; SB 203580 inhibits the reaction [icaritin results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:38431053 |
|
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
decreases expression |
ISO |
icaritin results in decreased expression of MDM2 protein |
CTD |
PMID:38431053 |
|
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Pgr |
progesterone receptor |
increases expression multiple interactions |
ISO |
icaritin results in increased expression of PGR mRNA Fulvestrant inhibits the reaction [icaritin results in increased expression of PGR mRNA] |
CTD |
PMID:16323292 |
|
NCBI chr 8:14,354,398...14,413,271
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pkm |
pyruvate kinase M1/2 |
decreases expression multiple interactions |
ISO |
icaritin results in decreased expression of PKM mRNA; icaritin results in decreased expression of PKM protein Acetylcysteine inhibits the reaction [icaritin results in decreased expression of PKM protein]; pifithrin inhibits the reaction [icaritin results in decreased expression of PKM mRNA]; pifithrin inhibits the reaction [icaritin results in decreased expression of PKM protein] |
CTD |
PMID:38431053 |
|
NCBI chr 8:68,949,731...68,975,394
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pou5f1 |
POU class 5 homeobox 1 |
decreases expression |
ISO |
icaritin results in decreased expression of POU5F1 mRNA |
CTD |
PMID:19135036 |
|
NCBI chr20:3,227,836...3,232,598
Ensembl chr20:3,223,129...3,227,891
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression multiple interactions |
ISO |
icaritin results in increased expression of PPARG mRNA; icaritin results in increased expression of PPARG protein icaritin inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA] icaritin inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA]; PPARG protein affects the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; PPARG protein affects the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]] |
CTD |
PMID:34153405 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
increases expression multiple interactions |
ISO |
icaritin results in increased expression of RUNX2 mRNA; icaritin results in increased expression of RUNX2 protein icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of RUNX2 protein] |
CTD |
PMID:30731080 |
|
NCBI chr 9:23,661,278...23,990,248
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions decreases expression |
ISO |
Acetylcysteine inhibits the reaction [icaritin results in decreased expression of SLC2A1 protein]; pifithrin inhibits the reaction [icaritin results in decreased expression of SLC2A1 mRNA]; pifithrin inhibits the reaction [icaritin results in decreased expression of SLC2A1 protein] icaritin results in decreased expression of SLC2A1 mRNA; icaritin results in decreased expression of SLC2A1 protein |
CTD |
PMID:38431053 |
|
NCBI chr 5:138,002,522...138,030,742
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Tbx1 |
T-box transcription factor 1 |
increases expression |
ISO |
icaritin results in increased expression of TBX1 mRNA |
CTD |
PMID:19135036 |
|
NCBI chr11:95,913,610...95,923,392
Ensembl chr11:82,409,275...82,418,380
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; icaritin inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA]; icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; icaritin inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA] 2-chloro-5-nitrobenzanilide inhibits the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; icaritin inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA]; icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mRNA]; icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; icaritin inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]; PPARG protein affects the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]; PPARG protein affects the reaction [icaritin inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]] |
CTD |
PMID:34153405 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
increases expression |
EXP |
icaritin results in increased expression of TNFRSF11B mRNA |
CTD |
PMID:17764702 |
|
NCBI chr 7:87,456,318...87,484,324
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
decreases expression |
EXP |
icaritin results in decreased expression of TNFSF11 mRNA |
CTD |
PMID:17764702 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [icaritin results in increased phosphorylation of TP53 protein]; icaritin results in decreased degradation of and results in increased expression of and results in increased phosphorylation of TP53 protein; SB 203580 inhibits the reaction [icaritin results in increased phosphorylation of TP53 protein] |
CTD |
PMID:38431053 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
increases expression |
ISO |
icaritin results in increased expression of TUBB3 protein |
CTD |
PMID:19135036 |
|
NCBI chr19:68,365,687...68,374,741
Ensembl chr19:51,457,184...51,466,243
|
|
G |
Wnt3a |
Wnt family member 3A |
increases expression multiple interactions |
ISO |
icaritin results in increased expression of WNT3A mRNA; icaritin results in increased expression of WNT3A protein icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A mRNA]; icaritin inhibits the reaction [[lead nitrate results in increased abundance of Lead] which results in decreased expression of WNT3A protein] |
CTD |
PMID:30731080 |
|
NCBI chr10:44,533,734...44,577,919
Ensembl chr10:44,034,194...44,078,324
|
|